1. Home
  2. AOSL vs DCTH Comparison

AOSL vs DCTH Comparison

Compare AOSL & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AOSL
  • DCTH
  • Stock Information
  • Founded
  • AOSL 2000
  • DCTH 1988
  • Country
  • AOSL United States
  • DCTH United States
  • Employees
  • AOSL N/A
  • DCTH N/A
  • Industry
  • AOSL Semiconductors
  • DCTH Medical/Dental Instruments
  • Sector
  • AOSL Technology
  • DCTH Health Care
  • Exchange
  • AOSL Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • AOSL 616.9M
  • DCTH 630.4M
  • IPO Year
  • AOSL 2010
  • DCTH N/A
  • Fundamental
  • Price
  • AOSL $24.12
  • DCTH $13.85
  • Analyst Decision
  • AOSL Buy
  • DCTH Strong Buy
  • Analyst Count
  • AOSL 3
  • DCTH 4
  • Target Price
  • AOSL $32.33
  • DCTH $24.00
  • AVG Volume (30 Days)
  • AOSL 371.0K
  • DCTH 508.4K
  • Earning Date
  • AOSL 08-06-2025
  • DCTH 08-04-2025
  • Dividend Yield
  • AOSL N/A
  • DCTH N/A
  • EPS Growth
  • AOSL N/A
  • DCTH N/A
  • EPS
  • AOSL N/A
  • DCTH N/A
  • Revenue
  • AOSL $680,974,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • AOSL $7.05
  • DCTH $155.42
  • Revenue Next Year
  • AOSL $2.54
  • DCTH $37.93
  • P/E Ratio
  • AOSL N/A
  • DCTH N/A
  • Revenue Growth
  • AOSL 3.57
  • DCTH 1068.87
  • 52 Week Low
  • AOSL $15.90
  • DCTH $7.17
  • 52 Week High
  • AOSL $53.29
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • AOSL 56.36
  • DCTH 37.03
  • Support Level
  • AOSL $22.79
  • DCTH $15.72
  • Resistance Level
  • AOSL $24.87
  • DCTH $17.35
  • Average True Range (ATR)
  • AOSL 1.20
  • DCTH 0.74
  • MACD
  • AOSL 0.05
  • DCTH -0.40
  • Stochastic Oscillator
  • AOSL 70.18
  • DCTH 2.23

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: